Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A DI PIETRO

Showing results (161-170 of 175) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosisF E Karet, F J Gainza, A Z Györy, et al.
Revista Iberoamericana De Micologia|March 15, 2005
Role of cell wall-degrading enzymes in pathogenicity of Fusarium oxysporumM I Roncero, A Di Pietro, M C Ruiz-Roldán, et al.
ACS Central Science|March 4, 2024
Prioritizing Mentorship as Scientific LeadersJacky M Deng, Salma Elgaili Ahmed, Ernest Awoonor-Williams, et al.
Cellular and Molecular Life Sciences : CMLS|March 28, 2002
Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transportersA Di Pietro, G Conseil, J M Pérez-Victoria, et al.
ESMO Open|September 3, 2021
Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]T K Choueiri, J Larkin, S Pal, et al.
ESMO Open|April 26, 2021
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trialT K Choueiri, J Larkin, S Pal, et al.
ESMO Open|May 4, 2023
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancerG Galffy, I Lugowska, E V Poddubskaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2020
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinomaT K Choueiri, R J Motzer, B I Rini, et al.
Nature Genetics|January 23, 1999
Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafnessF E Karet, K E Finberg, R D Nelson, et al.
Physical Review Letters|September 28, 2010
Elastic scattering and reaction mechanisms of the halo nucleus 11Be around the Coulomb barrierA Di Pietro, G Randisi, V Scuderi, et al.
Pageof 18

Showing results (161-170 of 175) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosisF E Karet, F J Gainza, A Z Györy, et al.
Revista Iberoamericana De Micologia|March 15, 2005
Role of cell wall-degrading enzymes in pathogenicity of Fusarium oxysporumM I Roncero, A Di Pietro, M C Ruiz-Roldán, et al.
ACS Central Science|March 4, 2024
Prioritizing Mentorship as Scientific LeadersJacky M Deng, Salma Elgaili Ahmed, Ernest Awoonor-Williams, et al.
Cellular and Molecular Life Sciences : CMLS|March 28, 2002
Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transportersA Di Pietro, G Conseil, J M Pérez-Victoria, et al.
ESMO Open|September 3, 2021
Erratum to 'Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial': [ESMO Open Volume 6, Issue 3, June 2021, 100101]T K Choueiri, J Larkin, S Pal, et al.
ESMO Open|April 26, 2021
Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trialT K Choueiri, J Larkin, S Pal, et al.
ESMO Open|May 4, 2023
A phase II open-label trial of avelumab plus axitinib in previously treated non-small-cell lung cancer or treatment-naïve, cisplatin-ineligible urothelial cancerG Galffy, I Lugowska, E V Poddubskaya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2020
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinomaT K Choueiri, R J Motzer, B I Rini, et al.
Nature Genetics|January 23, 1999
Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafnessF E Karet, K E Finberg, R D Nelson, et al.
Physical Review Letters|September 28, 2010
Elastic scattering and reaction mechanisms of the halo nucleus 11Be around the Coulomb barrierA Di Pietro, G Randisi, V Scuderi, et al.
Pageof 18